False-Positive Urine Drug Screens

Revision as of 07:50, 2 April 2016 by 68.82.234.138 (talk) (Created page with "from ClinicalPearl@EMedHome.com, http://www.emedhome.com Enzyme immunoassay qualitative techniques for urine toxicology screening are commonly used because of their wide av...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

from ClinicalPearl@EMedHome.com, http://www.emedhome.com


Enzyme immunoassay qualitative techniques for urine toxicology screening are commonly used because of their wide availability, lower cost and reduced testing time compared with nonimmunologic techniques. Commonly used medications can interact with immunoassay urine tests and result in false-positive results.

If a urine drug screen result is suspected of being falsely positive, confirmatory testing with a nonimmunologic, quantitative technique (e.g. mass spectroscopy) should be performed.


Cross-reactivity of commonly used medications in urine screening assays (1,2)
Drug identified in false-positive result Medication responsible for result
Opiate Levofloxacin, ofloxacin, rifampin
Amphetamine Bupropion, ephedrine, Vicks Vapor Inhaler
Barbiturate Ibuprofen, naproxen
Phencyclidine Venlafaxine, tramadol
Benzodiazepines Efavirenz (an HIV antiviral)
Methadone Quetiapine (Seroquel)


References:

(1) Tobin DG, et al. CCJM 2016 Mar;83(3):207-215.
(2) Saitman A, et al. J Anal Toxicol 2014;38(7):387-96.